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Abstract
Coccidiosis is a disease responsible for serious economic losses in the poultry industry. This paper compares the effect
of coccidiosis infection in a population of experimentally infected Castellana Negra chickens previously administered the
ionophorous antibiotic monensin (Treatment 1), Alquernat Zyox®, a herb-based product (Treatment 2), or a live vaccine
based on oocystes selected for precocity (Treatment 3). Fifty birds per treatment were housed in captivity and weighed indi-
vidually once every two weeks. At nine weeks they were infected with pathogenic oocysts of Eimeria tenella, E. acervuli-
na and E. maxima. No significant differences (P<0.05) were seen in body weight between the birds in the three treatment
groups after week 10. The average daily weight gain of the Alquernat Zycox®-treated and vaccinated birds was similar over
the entire experimental period, and more regular than that of the monensin-treated birds. The number of oocysts elimina-
ted in the faeces and the degree of intestinal injury caused were analysed at 10, 11 and 12 weeks. The vaccine-treated birds
shed a smaller number of oocysts in their faeces at 11 and 12 weeks than did those treated with monensin or Alquernat
Zycox® (P<0.001). At 11 and 12 weeks the vaccine- and Alquernat Zycox®-treated birds showed significantly (P<0.05)
less intestinal injury than the monensin-treated birds.
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Resumen
Comparación de diferentes métodos de control de coccidiosis en gallinas de la raza autóctona Castellana Negra
La coccidiosis es una parasitosis con gran incidencia económica en la industria avícola. En el presente trabajo se compa-
ran los efectos tras la infección experimental por coccidios en una población de pollos de raza Castellana Negra, utilizando
el antibiótico ionóforo monensina (Tratamiento 1), un producto natural como es Alquernat Zycox® (Tratamiento 2) y una
vacuna de ooquistes atenuados por precocidad (Tratamiento 3). Un total de 50 aves por grupo se alojaron en parques en cau-
tividad, las cuales se pesaron individualmente cada 2 semanas. A las 9 semanas se infectaron experimentalmente con ooquis-
tes patógenos de Eimeria tenella, E. acervulina y E. maxima. No hubo diferencias significativas entre el peso corporal de
los pollos de los distintos grupos en la semana 10. La ganancia media de peso diario de los pollos tratados con Alquernat
Zycox® y los vacunados fueron similares durante todo el periodo experimental. Es más, su crecimiento fue más regular que
el de los pollos tratados con monensina. A las 10, 11 y 12 semanas se analizó el número de ooquistes eliminados en las heces
y el grado de lesiones intestinales. Las aves vacunadas eliminaron una cantidad inferior de ooquistes que las tratadas con
monensina y también presentaron menor número de ooquistes en las heces a las 11 y 12 semanas postinfección que los tra-
tados con Alquernat Zycox® (P<0,001). El grado de lesiones a las 11 y 12 semanas fue significativamente inferior (P<0,05)
en las tratadas con la vacuna y con Alquernat Zycox® que en las tratadas con monensina.
Palabras clave adicionales: Alquernat Zycox®; Eimeria; monensina; ooquistes; vacuna.
Abbreviations used: ADGW (average daily gain in weight), EC (European Commission), PCA (pharmacological coccidiostatic agent).
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Introduction
Coccidiosis, a disease of poultry caused by Eimeria
spp., is responsible for serious economic losses - up to
€1500 million annually worldwide (Escoda, 2003).
Several anticoccidial drugs have been developed to help
control this problem. Monensin, an ionophorous anti-
biotic produced by Streptomyces cinnamonensis, has
long been the most used anticoccidial agent in the
poultry industry. However, despite the warnings made
(Ruff, 1993), resistance to almost all ionophorous anti-
biotics has now appeared (Chapman, 1993) (resistance
is probably the single most important factor in the demi-
se of the effectiveness of these drugs [Li et al., 2005]),
there are concerns about drug residues in poultry pro-
ducts, and there is a strong consumer desire to do away
with drugs in animal feeds. Recent norms (EC Directi-
ves 2092/1991 [OJ, 1991] and 1804/1999 [OJ, 1999])
require that poultry producers dispense with the use of
certain drugs when feeding their birds.
The pressing need to move away from the chemothe-
rapeutic control of coccidiosis has led to increased inte-
rest in vaccination. Many attenuated anticoccidial vacci-
nes are currently in use (Li et al., 2005). Various herb
extracts are also known to be effective against parasites
such as the malaria parasite, amoebae, trichomonads,
arthropods and helminths (Ou-Yang et al., 1990; Quan,
1990). Youn and Noh (2001) report on the efficacy of
extracts of Bupleurum chinese, Pulsatilla koreana, P.
aviculare, Ulmus macrocarpa, Sophora japonica, Tori-
lis nucifera, Quisqualis indica, Sophora flavescens and
Sophora acutum as anticoccidial agents.
The present work compares the effects of coccidiosis
in a population of experimentally infected Castellana
Negra chickens previously administered the ionopho-
rous antibiotic monensin, the herb extract Alquernat
Zycox®, or a vaccine.
Material and methods
The experimental birds used in this work were 1 day-
old males of the Castellana Negra chicken breed (a
breed native to Spain). These were assigned to three tre-
atment groups of 50 chicks each and housed in adjacent
pens over litter beds (4 birds m-2) for 12 weeks.
Treatment 1 birds were fed an ecological feed based
on cereal grains, products of oleaginous seeds, oils and
fats and minerals (see Table 1) supplemented with
monensin (50 ppm). Treatment 2 birds were administe-
red Alquernat Zycox® (BIOVET S.A., Tarragona,
Spain), a natural coccidiostatic agent (1000 ppm) made
from the extracts of Hollarrhena antidysenterica (30%),
Berberis aristata (30%), Allium sativum (15%) and
Embelia ribes (15%) the components of which include
phenols, essential oils, phytoproteins and a large quan-
tity of sulphated amino acids and glycosides. Treatment
3 birds received an attenuated vaccine (administered
orally on day 1 of life) prepared with a mixture of pre-
cocious strains of E. acervulina, E. maxima and E. tene-
lla (manufactured and administered by the Faculty of
Veterinary Medicine, University of Zaragoza, Spain).
Treatment 2 and 3 birds were fed the same feed provi-
ded to the Treatment 1 birds, but without the antibiotic.
Feed was provided ad libitum to all groups. When the
chickens were 9 weeks old, they were experimentally
infected with pathogenic oocysts derived from field
samples. The inoculum contained 10,000 E. tenella
oocysts, 100,000 E. acervulina oocysts, and 15,000 E.
maxima oocysts.
At 10, 11 and 12 weeks, 10 chickens from each group
were sacrificed and the degree of intestinal injury they
suffered determined. Briefly, samples of duodenum, the
middle third of the intestine and the caeca were exami-
ned by light microscopy and the injury they suffered
classified on the 4 point scale defined by Johnson and
Reid (1970): 0 = normal, 1 = mild injury, 2 = moderate
injury, 3 = serious injury, 4 = very serious injury with
death. Since the different species of Eimeria affect dif-
532 J. A. Miguel et al. / Span J Agric Res (2008) 6(4), 531-536
Nutrient contents %
Crude protein 19
Ether extract 6.4
Methionine 0.45
Gross fibre 3.6
Ash 5.1
Starch 30
Ca 0.85
P 0.65
Additives
Vitamin A (IU)a 10,000 
Vitamin D3 (IU) 2,000
Vitamin E (mg) 22
Cu (mg) 5
a IU: international units 
Table 1. Estimated nutrient content of the diet fed during the
trial
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ferent areas of the intestine and induce lesions with dif-
ferent characteristics (E. acervulina affects the upper
part of the small intestine, inducing white plaques; E.
maxima affects the mid small intestine, inducing small,
white, round lesions; E. tenella affects the caeca, indu-
cing thickening and haemorrhaging), those caused by
each species in the inoculum were recorded.
The mean number of oocysts per gram of faeces for
each treatment group at weeks 10, 11 and 12 was deter-
mined using the McMaster flotation method (Gordon
and Whitlock, 1939), as modified by Whitlock (1948). 
The body weight of each bird in each treatment group
was measured every two weeks, from the 4th until the
12th week (the end of the experimental period).
Differences between means were analysed using the
Student t test. All calculations were performed using
SPSS v.10.0 software for Windows (SPSS Inc., 1999).
Significance was set at P=0.05 for all variables except
oocyste number (P=0.01).
This study was approved by the Ethics Committee for
Animal Experimentation of the College of Agricultural
Engineers, University of Valladolid (Soria Campus),
Spain.
Results 
No deaths were recorded in any of the groups during
the course of the experiment. No significant differences
were seen in the mean body weight of the chickens of
any treatment group at any time (Table 2). The Treat-
ment 2 and 3 birds showed a more regular average daily
weight gain (ADGW) than the Treatment 1 birds. In
fact, the ADGW of the monensin-treated birds was
lower than that of the other groups until week 10, when
it became higher. However, in week 11 it fell once again
to below the values recorded for the Treatment 2 and 3
birds, only to rise to match them in week 12.
Table 3 shows that in weeks 10, 11 and 12 the vacci-
nated animals eliminated significantly fewer oocysts in
their faeces than those treated with monensin
(P<0.001). Indeed, throughout the experiment, the lar-
gest number of oocysts in faeces was recorded for the
monensin-treated birds. No significant differences were
found between the number of oocysts in the faeces of
the Alquernat Zycox®-treated and vaccinated birds in
week 10; in weeks 11 and 12 the Alquernat Zycox®-tre-
ated birds shed significantly more oocysts.
Table 4 shows the lesion severity results for the birds
at 10, 11 and 12 weeks considering all the species of
Eimeria as a whole. The vaccinated birds showed the
least serious injuries at all inspection times; the birds of
the other two treatment groups suffered significantly
more damage.
Table 4 shows the lesion severity suffered by the
three groups of birds taking into account the different
species of Eimeria separately. At week 10, there were
significantly fewer (P<0.05) lesions caused by E. tene-
lla and E. maxima in the vaccinated birds than in the
other treatment groups. No differences were seen bet-
ween the treatment groups with respect to damage cau-
sed by E. acervulina. In week 11, the damage caused by
E. tenella and E. maxima was the same in the vaccina-
ted and Alquernat Zycox®-treated birds. Also at 11
weeks, fewer E. Acervulina-induced lesions were seen
in the vaccinated birds than in the other treatment
Monensin Alquernat Zyox® Vaccine
Week
Weight (g) ADGW (g) Weight (g) ADGW (g) Weight (g) ADGW (g)
4 235.28a ± 30.4 225.35a ± 23.8 257.75a ± 40.3
6 476.61a ± 48.2 17.231 ± 2.1 447.83a ± 36.7 15.891 ± 2.2 470.47a ± 42.3 15.191 ± 2.5
8 802.23a ± 63.5 23.251 ± 3.2 774.53a ± 65.2 23.331 ± 2.9 796.32a ± 67.2 23.271 ± 3.0
9 (infection) 832.22a ± 76.4 7.492 ± 0.9 802.4a ± 69.2 6.962 ± 1.1 852.12a ± 77.8 13.951 ± 2.2
10 1126.0a ± 87.2 29.381 ± 2.4 995.58a ± 90.5 19.322 ± 2.4 1040.24a ± 88.3 18.812 ± 2.1
11 1140.2a ± 90.7 2.022 ± 0.2 1163.4a ± 93.2 23.971 ± 2.3 1219.3a ± 97.1 25.581 ± 3.1
12 1283.9a ± 97.7 20.51 ± 3.1 1334.6a ± 101.2 24.451 ± 3.2 1360.55a ± 92.3 24.461 ± 3.5
Means followed by different letters (weight) or numbers (ADGW) in the same row are significantly different (P<0.05)
Table 2. Mean ± standard deviation weight and average daily gain (ADGW) for the three treatment groups
groups. In week 12, the damage caused by E. tenella
and E. maxima was significantly greater in the birds tre-
ated with monensin than in the other treatment groups.
Finally, at 12 weeks, no differences were observed bet-
ween the groups in terms of E. Acervulina-induced
damage.
Discussion
The Castellana Negra breed, which belongs to the
class of slow-growing chicken lines, is a native of Spain
currently classified as endangered. However, it is extre-
mely hardy and disease-resistant, and is therefore a
potential meat producer of some interest.
Monensin works by modifying the passage of Na+
and K+ through the cell membrane, creating an osmotic
imbalance that finally destroys the parasite. In contrast,
Alquernat Zycox® affords protection by inducing the
optimum physiological state of the mucosa and impro-
ving local immunity. The vaccine used provides immu-
nological protection that lasts throughout life if admi-
nistered soon after hatching.
Pharmacological agents are the most common choice
for controlling coccidiosis in poultry since they can be
added to feed. However, the European Commission
(EC) has opted for restricting the use of pharmacologi-
cal coccidiostatic agents (PCAs); for example, EC
Directive 2205/2001 (OJ, 2001) bans the use of ampro-
lium, amprolium-ethopabate, dimetridazole, methylch-
lorpindol, nicarbazine and methylchlorpindol/methyl-
benzoquate. The possibility of PCAs losing their
category as feed additives has led to the search for other
control methods (among which vaccines and plant deri-
vatives appear to be the most effective). The substitution
of such products could avoid their residues accumula-
ting in meat as well as the interaction of these products
with others commonly used in the poultry industry, such
as antibiotics or antioxidants, etc. (Dowling, 1992). 
Vaccines containing attenuated Eimeria strains selec-
ted for precocity have been used extensively for several
years, and are associated with production results similar
to those achieved with PCAs (Shirley et al., 1995). Plant
derivatives have not been tested on a large scale in the
poultry industry, and their accumulation in poultry meat
and the possible organoleptic changes they may cause
are still to be determined. If good results are obtained,
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Week Monensin Alquernat Zyox® Vaccine
10 185,484a 44,672b 34,851b
11 246,216a 50,495b 17,411c
12 99,106a 19,074b 9,089c
Means followed by different letters in the same row are significantly
different (P<0.001).
Table 3. Mean number of oocysts per gram of faeces
Week Species Monensin Alquernat® Vaccine
10 E. tenella 2.75a 2.25ab 1.25b
E. acervulina 2.25a 1.75a 1.5a
E. maxima 2.5a 1.5ab 0.75b
Eimeria in bulk 2.6a 2.0ab 1.4b
11 E. tenella 3.25a 1.5b 1.25b
E. acervulina 2.0a 1.25ab 0.5b
E. maxima 2.25 a 0.75b 0.5b
Eimeria in bulk 3.2a 1.8b 1.4b
12 E. tenella 2.5a 1.25b 1.25b
E. acervulina 1.75a 1.0a 0.5a
E. maxima 2.25a 0.5b 0.75b
Eimeria in bulk 2.4a 1.4b 1.2b
Means followed by different letters in the same row are significantly different (p<0.05). Injury suffered : 1 = light injury; 2 = moderate injury;
3 = serious injury; 4 = very serious injury with mortality
Table 4. Mean intestinal damage (Johnson and Reid [1970]) caused by infection in each group of chickens. Results are shown
for each Eimeria species separately and as a whole
ted with a plant extract (Astragalus membranaceus) had
gained less weight than their vaccinated counterparts. 
The production of ecological chickens is regulated by
EC Directives 2092/1991 (OJ, 1991) and 1804/1999
(OJ, 1999), which prohibit the administration of phar-
macological products. Therefore, coccidiosis can only
be controlled via vaccines or plant derivatives registered
as “Dietetic Complements”. The present results, which
confirm those obtained by other authors, show that vac-
cination or the administration of plant-extract cocci-
diostatic agents are effective means of fighting cocci-
diosis in poultry. These alternative treatments appear to
be more effective than monensin treatment, possibly
because the massive use of this drug has generated
resistant strains (Chapman, 1993).
In conclusion, monensin was the least effective of the
three treatments tested and was associated with signifi-
cantly more serious intestinal lesions than seen with the
other treatments. Except for small variations at certain
times, treatment with Alquernat Zycox® or vaccination
appeared to be equally effective.
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